![](/img/cover-not-exists.png)
Phase I expansion cohort to evaluate the combination of bevacizumab, sorafenib and low-dose cyclophosphamide in children and young adults with refractory or recurrent solid tumours
Federico, Sara M., Caldwell, Kenneth J., McCarville, Mary B., Daryani, Vinay M., Stewart, Clinton F., Mao, Shenghua, Wu, Jianrong, Davidoff, Andrew M., Santana, Victor M., Furman, Wayne L., Pappo, AlbVolume:
132
Journal:
European Journal of Cancer
DOI:
10.1016/j.ejca.2020.03.010
Date:
June, 2020
File:
PDF, 765 KB
2020